-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 27, the official website of the National Medical Insurance Administration announced the "serious" and "particularly serious" untrustworthy evaluation results of price recruitment and procurement (1st issue of 2021), involving Harbin Yuheng Pharmaceutical Co.
The original text is as follows:
Evaluation results of “serious” and “particularly serious” untrustworthiness in price recruitment credit evaluation (first issue of 2021)
Entrusted by the National Medical Security Administration, the Medical Price and Bidding and Procurement Guidance Center of the National Medical Security Administration has compiled the status of the pharmaceutical companies rated as "serious" and "particularly serious" as untrustworthy in each province as of September 18, 2021.
1.
1.
2.
2.
3.
3.
4.
4.
5.
5.
